
BIOLASE BIOL
BIOLASE Gesamtverbindlichkeiten | BIOL
Gesamtverbindlichkeiten Jährlich BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.1 M | 33.3 M | 30.1 M | 31 M | 27.5 M | 27.4 M | 13.7 M | 19.9 M | 17.3 M | 17.3 M | 22.6 M | 20.2 M | 17.2 M | 21.2 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 33.3 M | 13.7 M | 23.7 M |
Gesamtverbindlichkeiten Vierteljährlich BIOLASE
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 32.1 M | 32.8 M | 34.1 M | 33.1 M | 32.9 M | 32.3 M | 33.8 M | 33.3 M | 29 M | 29.2 M | 29.6 M | 30.1 M | 28.2 M | 28 M | 30 M | 31 M | 28.1 M | 26.4 M | 25.4 M | 27.5 M | 29.3 M | 28.6 M | 26.8 M | 27.4 M | 17.9 M | 15.3 M | 15.4 M | 13.7 M | 16.2 M | 17 M | 18.7 M | 19.9 M | 18.6 M | 17 M | 16.8 M | 17.3 M | 20.8 M | 20.3 M | 17.6 M | 17.3 M | 18.8 M | 23.5 M | 19.7 M | 22.6 M | 23.4 M | 24.3 M | 20.8 M | 20.2 M | 18.4 M | 17.6 M | 16 M | 17.2 M | 15.1 M | 15 M | 17.2 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 34.1 M | 13.7 M | 23.4 M |
Gesamtverbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
518 M | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
45.2 M | - | - | $ 162 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
82.4 M | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | ||
|
LENSAR
LNSR
|
83.7 M | $ 5.6 | -2.78 % | $ 67 M | ||
|
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | ||
|
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | ||
|
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | ||
|
Outset Medical
OM
|
138 M | $ 4.04 | -4.49 % | $ 61.5 K | ||
|
AxoGen
AXGN
|
92.8 M | $ 39.49 | -0.6 % | $ 1.82 B | ||
|
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | ||
|
Insulet Corporation
PODD
|
1.68 B | $ 163.26 | 3.08 % | $ 11.5 B | ||
|
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | ||
|
Quanterix Corporation
QTRX
|
123 M | $ 3.67 | -6.38 % | $ 156 M | ||
|
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | ||
|
Bruker Corporation
BRKR
|
3.73 B | $ 60.45 | -2.74 % | $ 9.18 B | ||
|
Sintx Technologies
SINT
|
6.58 M | $ 1.42 | -6.58 % | $ 3.94 M | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | ||
|
TELA Bio
TELA
|
75.1 M | $ 0.69 | -2.81 % | $ 32.4 M | ||
|
Neovasc
NVCN
|
14 M | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | ||
|
Tactile Systems Technology
TCMD
|
55 M | $ 27.48 | 0.15 % | $ 629 M | ||
|
TransMedics Group
TMDX
|
595 M | $ 72.26 | 1.59 % | $ 2.46 B | ||
|
IRIDEX Corporation
IRIX
|
24.2 M | $ 0.89 | -3.38 % | $ 15.1 M | ||
|
Tandem Diabetes Care
TNDM
|
726 M | $ 17.12 | 1.3 % | $ 1.16 B | ||
|
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | ||
|
ClearPoint Neuro
CLPT
|
69.7 M | $ 14.12 | -2.55 % | $ 400 M | ||
|
Viemed Healthcare
VMD
|
55.6 M | $ 11.77 | 0.86 % | $ 458 M | ||
|
Avanos Medical
AVNS
|
296 M | $ 24.99 | 0.04 % | $ 1.16 B | ||
|
Beyond Air
XAIR
|
29.2 M | $ 5.16 | -5.67 % | $ 42.8 B | ||
|
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | ||
|
Xtant Medical Holdings
XTNT
|
43.2 M | $ 0.43 | -0.39 % | $ 60 M | ||
|
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.36 | -0.39 % | $ 22.4 M | ||
|
NanoVibronix
NAOV
|
7.63 M | - | - | $ 1.08 M | ||
|
NuVasive
NUVA
|
970 M | - | - | $ 2.07 B | ||
|
Natus Medical Incorporated
NTUS
|
140 M | - | 1.94 % | $ 1.05 B | ||
|
Nevro Corp.
NVRO
|
323 M | - | - | $ 217 M | ||
|
Inogen
INGN
|
106 M | $ 6.15 | -2.69 % | $ 164 M |